LEVOHEARTSHOCK

Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotropic use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. (LevoHeartShock)

Prof. Bruno LEVY

Coordinator of the LevoHeartShock project

Promoter: CHRU Nancy
Website
Coordinator: CIC-P
Website
LEVOHEARTSHOCK: Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. (LevoHeartShock)

Funded by the Ministry of Health PHRC 2018
CLINICALTRIALS.GOV